ADMA Biologics Inc.

NASDAQ: ADMA · Real-Time Price · USD
16.95
-0.02 (-0.12%)
At close: Aug 15, 2025, 3:59 PM
17.00
0.29%
After-hours: Aug 15, 2025, 07:08 PM EDT

ADMA Biologics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
121.98M 114.8M 117.55M 119.84M 107.19M 81.88M 73.9M 67.27M 60.12M 56.91M 49.98M 41.09M 33.91M 29.1M 26.38M 20.68M 17.83M 16.05M
Cost of Revenue
54.76M 53.7M 54.22M 60.18M 49.88M 42.96M 43M 42.62M 43.43M 40.4M 35.8M 31.43M 26.14M 25.44M 22.87M 20.3M 18.83M 17.77M
Gross Profit
67.23M 61.1M 63.33M 59.66M 57.31M 38.91M 30.9M 24.65M 16.69M 16.51M 14.18M 9.66M 7.77M 3.66M 3.51M 385.34K -1M -1.72M
Operating Income
42.8M 34.88M 38.32M 39.64M 39.2M 21.82M 14.23M 8.69M -473.08K -813.32K -6.06M -9.32M -9.17M -14.82M -13.19M -14.44M -15.58M -15.16M
Interest Income
400K 608K 598K 666K 449K 384K 612.45K 423.28K 414.3K 166.97K 2.26K 7.24K 2.27K 33.07K 2.29K 4.26K 5.93K 22.06K
Pretax Income
40.1M 33.45M 34.71M 36.75M 35.85M 18.4M -17.64M 2.57M -6.37M -6.79M -12.23M -14.9M -13.76M -25.01M -16.65M -17.71M -18.91M -18.38M
Net Income
34.22M 26.9M 111.9M 35.91M 32.06M 17.81M -17.64M 2.57M -6.37M -12.76M -12.23M -20.48M -13.76M -35.2M -16.65M -17.71M -18.91M -18.38M
Selling & General & Admin
22.21M 24.08M 24.59M 18.56M 17.55M 16.64M 16.22M 14.73M 14.25M 14.51M 13.89M 12.89M 11.97M 13.7M 11.7M 10.73M 10.44M 10.03M
Research & Development
1.03M 826K 391K 412K 560K 450K 445.49K 595.9K 1.4M 855.35K 1.07M 1.04M 873.39K 624.11K 728.99K 770.56K 1.16M 987.65K
Other Expenses
1.18M n/a 1.3M 1.05M -16K -35K -101.36K -145.83K -12.83K 1.96M 5.27M 5.04M -19.42K 4.15M -144.8K 18.55K -83.32K -42K
Operating Expenses
24.43M 24.91M 24.98M 20.02M 18.11M 17.09M 16.67M 15.97M 17.16M 17.33M 20.24M 18.97M 16.94M 18.48M 16.7M 14.82M 14.58M 13.44M
Interest Expense
1.83M 1.98M 2.88M 3.5M 3.78M 3.77M 6.21M 6.4M 6.3M 6.12M 5.74M 5.58M 4.57M 3.39M 3.32M 3.3M 3.25M 3.2M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
79.19M 78.61M 79.23M 80.2M 67.99M 60.05M 59.67M 58.59M 60.6M 57.73M 56.04M 50.41M 43.08M 43.92M 39.57M 35.12M 33.41M 31.21M
Income Tax Expense
5.88M 6.55M -77.18M 840K 3.79M 595K n/a n/a n/a 5.98M n/a 5.58M n/a 10.19M n/a n/a n/a n/a
Shares Outstanding (Basic)
241.49M 237.78M 236.43M 234.57M 232.42M 228.87M 225.97M 225.28M 222.68M 221.92M 202.83M 196.38M 196.35M 195.87M 180.81M 133.77M 126.04M 115.66M
Shares Outstanding (Diluted)
248.61M 244.68M 245.9M 244.8M 242.17M 236.41M 225.97M 233.76M 222.68M 221.92M 202.83M 196.38M 196.35M 195.87M 180.81M 133.77M 127.42M 115.66M
EPS (Basic)
0.14 0.11 0.47 0.15 0.14 0.08 -0.08 0.01 -0.03 -0.06 -0.06 -0.1 -0.07 -0.18 -0.09 -0.13 -0.15 -0.16
EPS (Diluted)
0.14 0.11 0.46 0.15 0.13 0.08 -0.08 0.01 -0.03 -0.06 -0.06 -0.1 -0.07 -0.18 -0.09 -0.13 -0.15 -0.16
EBITDA
43.99M 37.39M 39.54M 42.19M 41.68M 23.93M -9.32M 11.06M 2.03M 1.36M -4.56M -7.46M -7.47M -20.03M -11.82M -12.99M -14.33M -13.95M
EBIT
41.93M 35.42M 37.59M 40.25M 39.63M 21.82M -11.43M 9.39M -71.6K -673.33K -6.49M -9.32M -9.19M -21.62M -13.33M -14.41M -15.66M -15.18M
Depreciation & Amortization
2.06M 1.97M 1.94M 1.94M 2.05M 2.11M 2.11M 2.09M 2.1M 2.03M 1.94M 1.86M 1.72M 1.59M 1.52M 1.42M 1.33M 1.23M